UT Southwestern biotech company lands another $80M about 18 months after last raise

//UT Southwestern biotech company lands another $80M about 18 months after last raise

UT Southwestern biotech company lands another $80M about 18 months after last raise

ReCode Therapeutics is gearing up for human clinical trials of its primary ciliary dyskinesia (PCD) and cystic fibrosis therapies next year.

Article by [author-name] (c) Technology News - Technology News Headlines | Bizjournals.com - Read full story here.

By | 2021-10-23T03:59:00+00:00 October 23rd, 2021|Technology|

About the Author: